Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Neurophysiologist Perspective into MS Plasticity.
Diversity Matters: A Revised Guide to Myelination.
[Remyelination strategy for multiple sclerosis].
Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.
Currently Approved And Emerging Oral Therapies In Multiple Sclerosis: An Update For The Ophthalmologist.
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation.
EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE).
Clinical Relevance of Serum Aquaporin-4 Antibody Levels in Neuromyelitis Optica.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Remodeling myelination: implications for mechanisms of neural plasticity.
Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
High-throughput sequencing of immune repertoires in multiple sclerosis.
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis.
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.
Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis.
Sex Chromosome Complement Influences Functional Callosal Myelination.
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid.
Negative work events and accommodations in employed multiple sclerosis patients.
Role of toll-like receptors in multiple sclerosis.
Interference of upper limb tremor on daily life activities in people with multiple sclerosis.
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?

Pages